Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

The FDA has approved Dupixent (dupilumab) as an add-on therapy for adults with poorly controlled COPD, especially those with ...

In the United States, more than 10 million people above the age of 40 live with chronic obstructive pulmonary disease (COPD), a chronic lung disease that limits air flow and causes ...

These symptoms could be early signs of COPD (Chronic Obstructive Pulmonary Disease), a progressive lung disease that is one of the leading causes of illness and death worldwide. COPD is caused by ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

A recent study found that the respiratory and non-respiratory symptom burden in patients with COPD is high when compared with ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

Treatment with Ohtuvayre in COPD was linked to improved lung function and other benefits across key patient subgroups in ...

1 Looking back, he recognizes there were many missed signs prior to this flare-up, also known as a COPD exacerbation. Flare-ups are characterized by worsening COPD symptoms that require medical ...

A project to pick up undiagnosed COPD in people who had attended lung health checks found 70% had the condition.

In the US, more than 10 million people above the age of 40 live with chronic obstructive pulmonary disease, or COPD. We're discussing a new treatment option that may help patients.